Pueraria Menopause Randomized Trial Evidence Table

Structured evidence table for Pueraria Menopause Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Pueraria Menopause Randomized TrialIt has long been utilized in ethnomedicine for estrogen-related conditions and age-associated functional decline.3Zeng H (2026)<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
Pueraria Menopause Randomized TrialThis review critically evaluates the nexus between its botanical characteristics, traditional ethnopharmacological uses, and contemporary evidence regarding its therapeutic potential.3Zeng H (2026)<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
Pueraria Menopause Randomized TrialMaterials and methods A structured literature search was conducted across multiple international and Chinese databases up to 2025, with screening based on predefined inclusion and exclusion criteria focusing on botanical identity, chemical composition, pharmacological activity, toxicological evidence, and clinical findings.3Zeng H (2026)<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
Pueraria Menopause Randomized Trialmirifica (Airy Shaw and Suvat.) Niyomdham ( Pueraria mirifica ), locally known as "White Kwao Krua" or "white kudzu", is a renowned medicinal botanical drug indigenous to Southeast Asia, particularly Thailand and Myanmar.3Zeng H (2026)<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
Pueraria Menopause Randomized TrialThe herbal gel group demonstrated a more significant reduction in atrophic vaginitis indicators compared to placebo (P Conclusion Both interventions effectively reduced symptoms and improved quality of life, but the herbal gel outperformed auriculotherapy in reducing dryness and enhancing sexual function.4Naderi-Afshar E (2026)Effect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy.
Pueraria Menopause Randomized TrialBackground Vaginal atrophy is a common condition in postmenopausal women due to low estrogen causing dryness, irritation, infections, and painful intercourse.4Naderi-Afshar E (2026)Effect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy.
Pueraria Menopause Randomized TrialTreatments include non-hormonal (moisturizers, lubricants) and hormonal options (vaginal estrogens, phytoestrogens) Moreover, Traditional Persian medicine suggests plants as a potential remedy for vaginal atrophy.4Naderi-Afshar E (2026)Effect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy.
topicPueraria Menopause Randomized Trial
claimIt has long been utilized in ethnomedicine for estrogen-related conditions and age-associated functional decline.
evidence level3
citationZeng H (2026)
source<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
topicPueraria Menopause Randomized Trial
claimThis review critically evaluates the nexus between its botanical characteristics, traditional ethnopharmacological uses, and contemporary evidence regarding its therapeutic potential.
evidence level3
citationZeng H (2026)
source<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
topicPueraria Menopause Randomized Trial
claimMaterials and methods A structured literature search was conducted across multiple international and Chinese databases up to 2025, with screening based on predefined inclusion and exclusion criteria focusing on botanical identity, chemical composition, pharmacological activity, toxicological evidence, and clinical findings.
evidence level3
citationZeng H (2026)
source<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
topicPueraria Menopause Randomized Trial
claimmirifica (Airy Shaw and Suvat.) Niyomdham ( Pueraria mirifica ), locally known as "White Kwao Krua" or "white kudzu", is a renowned medicinal botanical drug indigenous to Southeast Asia, particularly Thailand and Myanmar.
evidence level3
citationZeng H (2026)
source<i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
topicPueraria Menopause Randomized Trial
claimThe herbal gel group demonstrated a more significant reduction in atrophic vaginitis indicators compared to placebo (P Conclusion Both interventions effectively reduced symptoms and improved quality of life, but the herbal gel outperformed auriculotherapy in reducing dryness and enhancing sexual function.
evidence level4
citationNaderi-Afshar E (2026)
sourceEffect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy.
topicPueraria Menopause Randomized Trial
claimBackground Vaginal atrophy is a common condition in postmenopausal women due to low estrogen causing dryness, irritation, infections, and painful intercourse.
evidence level4
citationNaderi-Afshar E (2026)
sourceEffect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy.
topicPueraria Menopause Randomized Trial
claimTreatments include non-hormonal (moisturizers, lubricants) and hormonal options (vaginal estrogens, phytoestrogens) Moreover, Traditional Persian medicine suggests plants as a potential remedy for vaginal atrophy.
evidence level4
citationNaderi-Afshar E (2026)
sourceEffect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy.

Source documents

  1. <i>Pueraria mirifica</i>: a critical review of the ethnobotany, phytochemistry, pharmacology and challenges in standardization and safety.
  2. Effect of Persian traditional medicine based herbal vaginal gel in vaginal atrophy.